榮昌生物(09995.HK)實際控制人擬以不逾2,000萬元人幣增持
榮昌生物(09995.HK)(688331.SH)公布,實際控制人王威東、房健民、林健、王荔強、王旭東、鄧勇、熊曉濱、楊敏華、溫慶凱及魏建良,擬於今日(1日)起六個月內,通過所控制的企業煙台榮昌控股,以上海證券交易所包括集中競價、連續競價和大宗交易方式增持股份,增持金額不低於1,000萬至不多於2,000萬元人民幣。
公司指,增持未設置固定價格及價格區間。相關人士增持是因為對公司經營情況持續看好,以及對未來發展前景具有信心。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.